Heidelberg Pharma AG (HPHA) — Capital Reinvestment Ratio
Latest as of May 2022:
0.00x
Heidelberg Pharma AG (HPHA) has a Capital Reinvestment Ratio of 0.00x as of May 2022, meaning it reinvests 0% of its operating cash flow (€13.59 Million) in capital expenditures (€50.81K). See cash generation quality of Heidelberg Pharma AG to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
€13.59 Million
EUR
Capital Expenditures
€50.81K
EUR
Data as of
May 2022
Most recent filing
Annual Capital Reinvestment Ratio for Heidelberg Pharma AG (None–None)
Year-by-year Capital Reinvestment Ratio for Heidelberg Pharma AG from None to None. For live market cap and broader valuation context, see Heidelberg Pharma AG market capitalisation.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow